Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in TXG — 10x Genomics, Inc.

CIK 820027 MINNEAPOLIS, MN
Back to TXG Full portfolio

Position in TXG

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,039,268
+$1,979,785 QoQ
Shares Held
235,766
-29.1% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 75% None 25%

Common Shares in TXG Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $4,250,067,609 across 57 Medical Devices names. TXG ranks #23 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SYK
Stryker Corp
 3,272,554 $1,030,330,898
2 ABT
Abbott Laboratories
 10,705,270 $971,396,196
3 MDT
Medtronic plc
 11,565,988 $904,807,237
4 DXCM
Dexcom Inc
 4,820,775 $324,679,192
5 BSX
Boston Scientific Corp
 5,134,220 $219,128,506
6 GKOS
GLAUKOS Corp
 1,315,057 $183,792,363
7 ZBH
Zimmer Biomet Holdings, Inc.
 1,040,975 $89,617,535
8 PODD
Insulet Corp
 506,374 $77,095,440

All Filings in TXG

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,039,268 235,766
2026-03-31 $7,059,483 332,524
2025-12-31 $6,249,486 383,169
2025-09-30 $3,999,628 342,141
2025-06-30 $5,138,613 443,749
2025-03-31 $1,140,041 130,589
2024-09-30 $1,747,036 77,371
2024-06-30 $1,177,910 60,561
2024-03-31 $17,502,264 466,354
2023-12-31 $28,838,481 515,341
2023-09-30 $599,733 14,539
2023-06-30 $1,696,642 30,384
2023-03-31 $2,963,563 53,120
2022-12-31 $2,143,545 58,824
2022-09-30 $1,502,802 52,767
2022-06-30 $2,602,508 57,514
2022-03-31 $124,442,605 1,635,896
2021-12-31 $237,631,266 1,595,269
2021-09-30 $156,439,975 1,074,598
2021-06-30 $260,386,159 1,329,722
2021-03-31 $255,066,467 1,409,207
2020-12-31 $194,223,373 1,371,634
2020-09-30 $95,392,168 765,096
2020-06-30 $48,305,724 540,877
2020-03-31 $12,021,714 192,903